- Home
- VTYX vs BKSY Comparison
VTYX vs BKSY Comparison
Compare VTYX & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- BKSY
- Stock Information
- Founded
- VTYX 2018
- BKSY 2013
- Country
- VTYX United States
- BKSY United States
- Employees
- VTYX N/A
- BKSY N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- BKSY Radio And Television Broadcasting And Communications Equipment
- Sector
- VTYX Health Care
- BKSY Technology
- Exchange
- VTYX Nasdaq
- BKSY Nasdaq
- Market Cap
- VTYX 148.4M
- BKSY 149.8M
- IPO Year
- VTYX 2021
- BKSY N/A
- Fundamental
- Price
- VTYX $1.73
- BKSY $10.64
- Analyst Decision
- VTYX Buy
- BKSY Strong Buy
- Analyst Count
- VTYX 5
- BKSY 5
- Target Price
- VTYX $8.40
- BKSY $17.60
- AVG Volume (30 Days)
- VTYX 1.1M
- BKSY 1.2M
- Earning Date
- VTYX 11-07-2024
- BKSY 11-07-2024
- Dividend Yield
- VTYX N/A
- BKSY N/A
- EPS Growth
- VTYX N/A
- BKSY N/A
- EPS
- VTYX N/A
- BKSY N/A
- Revenue
- VTYX N/A
- BKSY $107,231,000.00
- Revenue This Year
- VTYX N/A
- BKSY $16.01
- Revenue Next Year
- VTYX N/A
- BKSY $25.73
- P/E Ratio
- VTYX N/A
- BKSY N/A
- Revenue Growth
- VTYX N/A
- BKSY 36.77
- 52 Week Low
- VTYX $1.67
- BKSY $3.86
- 52 Week High
- VTYX $11.48
- BKSY $14.16
- Technical
- Relative Strength Index (RSI)
- VTYX 30.10
- BKSY 75.92
- Support Level
- VTYX $2.10
- BKSY $6.94
- Resistance Level
- VTYX $2.36
- BKSY $9.83
- Average True Range (ATR)
- VTYX 0.12
- BKSY 0.84
- MACD
- VTYX -0.05
- BKSY 0.29
- Stochastic Oscillator
- VTYX 8.76
- BKSY 94.00
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.